EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Genetics and Pathophysiological Mechanisms of Lipoprotein(a)‐Associated Cardiovascular Risk

Annabelle Santos Volgman iD, Marlys L Koschinsky iD, Anurag Mehta iD, Robert S Rosenson iD

Journal of the American Heart Association · 18.06.2024 · 13 (12)

DOI: 10.1161/jaha.123.033654 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, erschienen am 18.06.2024. Verfasst von Annabelle Santos Volgman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology Rush University Medical Center Chicago IL USA. Hauptthemen laut MEDLINE: Lipoprotein(a), Cardiovascular Diseases. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elevated lipoprotein(a) is a genetically transmitted codominant trait that is an independent risk driver for cardiovascular disease. Lipoprotein(a) concentration is heavily influenced by genetic factors, including LPA kringle IV‐2 domain size, single‐nucleotide polymorphisms, and interleukin‐1 genotypes. Apolipoprotein(a) is encoded by the LPA gene and contains 10 subtypes with a variable number of copies of kringle ‐2, resulting in >40 different apolipoprotein(a) isoform sizes. Genetic loci beyond LPA , such as APOE and APOH , have been shown to impact lipoprotein(a) levels. Lipoprotein(a) concentrations are generally 5% to 10% higher in women than men, and there is up to a 3‐fold difference in median lipoprotein(a) concentrations between racial and ethnic populations. Nongenetic factors, including menopause, diet, and renal function, may also impact lipoprotein(a) concentration. Lipoprotein(a) levels are also influenced by inflammation since the LPA promoter contains an interleukin‐6 response element; interleukin‐6 released during the inflammatory response results in transient increases in plasma lipoprotein(a) levels. Screening can identify elevated lipoprotein(a) levels and facilitate intensive risk factor management. Several investigational, RNA‐targeted agents have shown promising lipoprotein(a)‐lowering effects in clinical studies, and large‐scale lipoprotein(a) testing will be fundamental to identifying eligible patients should these agents become available. Lipoprotein(a) testing requires routine, nonfasting blood draws, making it convenient for patients. Herein, we discuss the genetic determinants of lipoprotein(a) levels, explore the pathophysiological mechanisms underlying the association between lipoprotein(a) and cardiovascular disease, and provide practical guidance for lipoprotein(a) testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoprotein(a)Cardiovascular DiseasesHumansHeart Disease Risk FactorsGenetic Predisposition to DiseaseRisk AssessmentPhenotype

Stichwörter der Autor:innen

atherosclerotic cardiovascular diseasecardiovascular riskcoronary heart diseasegeneticslipoprotein(a)oxidized phospholipidssingle nucleotide polymorphisms

Substanzen

Lipoprotein(a)LPA protein, human

Autor:innen und Institutionen

  • Division of Cardiology Rush University Medical Center Chicago IL USA.
  • Robarts Research Institute, Schulich School of Medicine and Dentistry Western University London ON Canada.
  • VCU Health Pauley Heart Center Richmond VA USA.
  • Metabolism and Lipids Program, Mount Sinai Fuster Heart Hospital Icahn School of Medicine at Mount Sinai New York NY USA.

ORCID-Profile: Annabelle Santos Volgman, Marlys L Koschinsky, Anurag Mehta, Robert S Rosenson

Zitieren

APA

Volgman, A. S., Koschinsky, M. L., Mehta, A., & Rosenson, R. S. (2024). Genetics and Pathophysiological Mechanisms of Lipoprotein(a)‐Associated Cardiovascular Risk. Journal of the American Heart Association, 13(12). https://doi.org/10.1161/jaha.123.033654

Vancouver

Volgman AS, Koschinsky ML, Mehta A, Rosenson RS. Genetics and Pathophysiological Mechanisms of Lipoprotein(a)‐Associated Cardiovascular Risk. Journal of the American Heart Association. 2024;13(12). doi:10.1161/jaha.123.033654

BibTeX
@article{Volgman2024,
  author = {Volgman, Annabelle Santos and Koschinsky, Marlys L and Mehta, Anurag and Rosenson, Robert S},
  title = {Genetics and Pathophysiological Mechanisms of Lipoprotein(a)‐Associated Cardiovascular Risk},
  journal = {Journal of the American Heart Association},
  year = {2024},
  volume = {13},
  number = {12},
  doi = {10.1161/jaha.123.033654}
}
Kostenlos starten →